Effectiveness of Exercise Plus Pain Neuroscience Education on Brain Function in Knee Osteoarthritis
Brain Function, Clinical and Psychosocial Outcomes After Neuromuscular Exercise Plus Pain Neuroscience Education Intervention in Patients With Chronic Pain Due to Knee Osteoarthritis. A Randomized Controlled Trial Protocol
1 other identifier
interventional
57
0 countries
N/A
Brief Summary
A three-arm randomized controlled trial will be conducted. Fifty-nine participants with KOA will be recruited in a 1:1:1 ratio. Assessor, and statistician will be blinded to group allocation. One experimental group (n=19) will receive NME plus PNE, the other experimental group (n=19) will receive isolated NME and the control group (n=19) will continue with usual care. The PNE will be adapted to the context of the participants. Outcome measures will be brain activity, pressure pain threshold, pain intensity, disability, fear-avoidance beliefs, self-efficacy, and pain catastrophizing. Outcome measures will be evaluated pre-intervention, immediately post-intervention, and four-month post-intervention. The investigators hypothesize that there will be significant differences in favor of the NME plus PNE intervention group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable knee-osteoarthritis
Started Mar 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2024
CompletedFirst Posted
Study publicly available on registry
July 1, 2024
CompletedStudy Start
First participant enrolled
March 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedJuly 1, 2024
June 1, 2024
9 months
June 20, 2024
June 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Brain function (peak frequency)
An analysis of the peak frequencies (the highest power frequency determined in the average of the windows as the local maximum (greater than its two neighboring windows) of the amplitude in a frequency range of 6-14 Hz will be applied.
baseline, post-intervention (2 months after admission), follow-up four months after the intervention.
Brain function (power spectrum)
A global analysis of the power spectrum will be carried out, considered as the average of all the electrodes, which represents the synchronization between the neurons to generate the discharges. A topographic power analysis will also be performed for the Delta (0.1 - 4 Hz), theta (4 - 8 Hz), alpha (8 - 13 Hz) and beta (13 - 30 Hz) frequency bands.
baseline, post-intervention (2 months after admission), follow-up four months after the intervention.
Secondary Outcomes (6)
Pain pressure-threshold
baseline, post-intervention (2 months after admission), follow-up four months after the intervention.
Pain intensity
baseline, post-intervention (2 months after admission), follow-up four months after the intervention.
Disability
baseline, post-intervention (2 months after admission), follow-up four months after the intervention.
Fear-avoidance beliefs
baseline, post-intervention (2 months after admission), follow-up four months after the intervention.
Self-efficacy
baseline, post-intervention (2 months after admission), follow-up four months after the intervention.
- +1 more secondary outcomes
Study Arms (3)
Neuromuscular exercise plus Pain neuroscience education
EXPERIMENTALNeuromuscular exercise will be carried out for eight weeks, with three weekly sessions, in groups (up to five participants per group). Each session will consist of three parts: warm-up, exercise circuit and cool down. Each part will be regulated for the abilities of the participants Pain neuroscience education will be carried in group using visual support for Powerpoint presentations. The PNE will include five dimensions with a focus on reducing fear-avoidance beliefs and catastrophic thoughts to promote self-efficacy. Five PNE sessions will be carried out, one for each dimension, with a duration of 30-45 minutes each taught during the first five sessions of the intervention. In addition, a brochure will be delivered with the main points of each of the domains and an informative video will be made to which participants will have access (five 15-minute videos, one per domain).
Neuromuscular exercise
EXPERIMENTALNeuromuscular exercise will be carried out for eight weeks, with three weekly sessions, in groups (up to five participants per group). Each session will consist of three parts: warm-up, exercise circuit and cool down. Each part will be regulated for the abilities of the participants
Usual care
NO INTERVENTIONParticipants will be urged to continue with their life activities without changes. All participants will continue to receive routine care offered by their doctor and other health care providers. No trial interventions were provided. The possible treatments that may be provided to the participants in this group (if the primary medical team deems it appropriate) will not be influenced. However, if the participants receive any treatment from their medical staff, it will be recorded as an extra history and the participant will not be considered in the analyses. All participants in this group will be eligible to receive the experimental therapies of their choice once the study is completed.
Interventions
The exercises follow neuromuscular principles, which aim to improve sensorimotor control and achieve compensatory functional stability (also called dynamic stability). Pain neuroscience education will take an active, person-centered approach through their own fear-avoidance beliefs.
The exercises follow neuromuscular principles, which aim to improve sensorimotor control and achieve compensatory functional stability (also called dynamic stability).
Eligibility Criteria
You may qualify if:
- women and men at least 45 years old radiologically diagnosed with unilateral or bilateral KOA (Kellgren-Lawrence 1-3 grading scale)
- pain duration greater than three months
You may not qualify if:
- Patients who have received physical therapy or other conservative therapy in the previous three months and those who have a history of major knee trauma and surgery in the last six months
- cardiac pathology
- structural use of psychoactive medications, such as antipsychotics, antidepressants, antiepileptics, and anxiolytics, during the past year
- neurological diseases
- other musculoskeletal clinical conditions that generate pain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joaquín I Salazar, MSc
Universidad Santo Tomás
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
June 20, 2024
First Posted
July 1, 2024
Study Start
March 15, 2025
Primary Completion
November 30, 2025
Study Completion
December 30, 2025
Last Updated
July 1, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- from 6 months after publication. They will be available for one year
- Access Criteria
- will be provided to any researcher who requires it via email
all collected IPD, all IPD that underlie results in a publication